Oncogenic KRAS: Signaling and Drug Resistance
RAS proteins play a role in many physiological signals transduction processes, including cell growth, division, and survival. The Ras protein has amino acids 188-189 and functions as GTPase. These proteins are switch molecules that cycle between inactive GDP-bound and active GTP-bound by guanine nuc...
Guardado en:
Autores principales: | Hyeon Jin Kim, Han Na Lee, Mi Suk Jeong, Se Bok Jang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/08d2cd764940497dbfb63f5269529f3d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Small-Molecule Inhibitors and Degraders Targeting KRAS-Driven Cancers
por: Soonsil Hyun, et al.
Publicado: (2021) -
Intracellular nanoparticle delivery by oncogenic KRAS-mediated macropinocytosis
por: Liu X, et al.
Publicado: (2019) -
CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma
por: Cai,Yi, et al.
Publicado: (2018) -
Abemaciclib in Combination With Pembrolizumab for Stage IV KRAS-Mutant or Squamous NSCLC: A Phase 1b Study
por: Jean-Louis Pujol, MD, PhD, et al.
Publicado: (2021) -
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer
por: Gongmin Zhu, et al.
Publicado: (2021)